日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characteristics of Intestinal Barrier State and Immunoglobulin-Bound Fraction of Stool Microbiota in Advanced Melanoma Patients Undergoing Anti-PD-1 Therapy.

接受抗 PD-1 治疗的晚期黑色素瘤患者的肠道屏障状态和粪便微生物群免疫球蛋白结合部分的特征

Drymel Bernadeta, Tomela Katarzyna, Galus Łukasz, Olejnik-Schmidt Agnieszka, Mackiewicz Jacek, Kaczmarek Mariusz, Mackiewicz Andrzej, Schmidt Marcin

Discontinuation of Immune Checkpoint Inhibition in Patients with Advanced Unresectable Melanoma Achieving CR, PR, or SD

对于达到完全缓解 (CR)、部分缓解 (PR) 或疾病稳定 (SD) 的晚期不可切除黑色素瘤患者,应停止免疫检查点抑制剂治疗。

Czarnecka, Anna M; Teterycz, Paweł; Ostaszewski, Krzysztof; Błoński, Piotr; Zielińska, Magdalena; Galus, Łukasz; Dziura, Robert; Kempa-Kamińska, Natasza; Galwas, Katarzyna; Cybulska-Stopa, Bożena; Mackiewicz, Jacek; Ziętek, Marcin; Kamińska-Winciorek, Grażyna; Kozak, Katarzyna; Rutkowski, Piotr

lncRNA EGOT Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients

lncRNA EGOT是HPV感染的标志物,也是头颈部鳞状细胞癌患者的预后因素。

Kolenda, Tomasz; Białas, Piotr; Guglas, Kacper; Stasiak, Maciej; Kozłowska-Masłoń, Joanna; Tylkowska, Karina; Zapłata, Anna; Poter, Paulina; Janiczek-Polewska, Marlena; Mantaj, Patrycja; Gieremek, Paulina; Kazimierczak, Urszula; Przybyła, Anna; Regulska, Katarzyna; Stanisz, Beata; Leporowska, Ewa; Mackiewicz, Andrzej; Mackiewicz, Jacek; Kazmierska, Joanna; Cybulski, Zefiryn; Teresiak, Anna

Pair-matched analysis of Circulating Melanoma Cells (CMCs) before and after Immunotherapy in Relation to other Melanoma-Specific Biomarkers.

对免疫治疗前后循环黑色素瘤细胞 (CMC) 与其他黑色素瘤特异性生物标志物的关系进行配对分析

Sawerska Paula, Konwerska Aneta, Galus Łukasz, Kolecka-Bednarczyk Agata, Buszka Karolina, Rusek Damian, Seraszek-Jaros Agnieszka, Nowicki Michał, Mackiewicz Jacek, Budna-Tukan Joanna

Harnessing the synergy of contact brachytherapy and immune checkpoint inhibitors in advanced melanoma: first reported case series

利用接触式近距离放射疗法和免疫检查点抑制剂的协同作用治疗晚期黑色素瘤:首例病例系列报告

Chyrek, Artur Jan; Galus, Łukasz; Mackiewicz, Jacek; Kluska, Adam; Burchardt, Wojciech Maria; Chicheł, Adam

Elevated lactate dehydrogenase in adjuvant BRAF and MEK inhibitor therapy does not have diagnostic significance in detecting melanoma recurrence

辅助性BRAF和MEK抑制剂治疗中乳酸脱氢酶升高对检测黑色素瘤复发没有诊断意义。

Galus, Łukasz; Tusień-Małecka, Daria; Mackiewicz, Jacek

Chemotherapy efficacy in advanced melanoma patients after failure of immune checkpoint and BRAF/MEK inhibitors

免疫检查点抑制剂和BRAF/MEK抑制剂治疗失败后,化疗对晚期黑色素瘤患者的疗效

Galus, Łukasz; Małecka, Daria Tusień; Michalak, Michał; Kopeć, Sylwia; Kozak, Katarzyna; Piejko, Karolina; Ziętek, Marcin; Chowaniec, Zbyszko; Stopa, Bożena Cybulska; Dziura, Robert; Żubrowska, Justyna; Winciorek, Grażyna Kamińska; Bal, Wiesław; Rutkowski, Piotr; Mackiewicz, Jacek

Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

出版商更正:辅助性纳武利尤单抗治疗切除术后的 IIB/C 期黑色素瘤:来自随机、3 期 CheckMate 76K 试验的主要结果

Kirkwood, John M; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M; Ascierto, Paolo A; Menzies, Alexander M; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina V

Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

作者更正:辅助性纳武利尤单抗治疗切除术后的 IIB/C 期黑色素瘤:来自随机、3 期 CheckMate 76K 试验的主要结果

Kirkwood, John M; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M; Ascierto, Paolo A; Menzies, Alexander M; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina V

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study

帕博利珠单抗与安慰剂作为切除术后 IIB 或 IIC 期黑色素瘤辅助治疗的疗效比较:KEYNOTE-716 III 期研究的远处转移无进展生存期最终分析

Luke, Jason J; Ascierto, Paolo A; Khattak, Muhammad A; de la Cruz Merino, Luis; Del Vecchio, Michele; Rutkowski, Piotr; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Kirkwood, John M; Robert, Caroline; Grob, Jean-Jacques; de Galitiis, Federica; Schadendorf, Dirk; Carlino, Matteo S; Wu, Xi Lawrence; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M M; Long, Georgina V